إعلان
إعلان
ALLR
Allarity Therapeutics, Inc. Common Stock
1.18
USDبرعاية
-0.01
-1.26%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
1.20
+0.02
+1.70%
تقارير أرباح ALLR
النسبة الإيجابية المفاجئة
ALLR تفوق 7 من 12 آخر التقديرات.
58%
التقرير التالي
بيانات التقرير القادم
٣١ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.22
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+15.79%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/--
Allarity Therapeutics, Inc. Common Stock earnings per share and revenue
On ١٤ نوفمبر ٢٠٢٥, ALLR reported earnings of -0.19 USD per share (EPS) for Q3 25, beating the estimate of -0.23 USD, resulting in a 19.01% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.84% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -0.22 USD, with revenue projected to reach -- USD, implying an زيادة of 15.79% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Allarity Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Allarity Therapeutics, Inc. Common Stock reported EPS of -$0.19, beating estimates by 19.01%, and revenue of $0.00, 0% as expectations.
How did the market react to Allarity Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -0.84%, changed from $1.19 before the earnings release to $1.18 the day after.
When is Allarity Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٣١ مارس ٢٠٢٦.
What are the forecasts for Allarity Therapeutics, Inc. Common Stock's next earnings report?
Based on 3
المحللين, Allarity Therapeutics, Inc. Common Stock is expected to report EPS of -$0.22 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان